FDA OKs First Once-Daily IV COX-2 Preferential NSAID for Pain
The FDA approved meloxicam injection (Anjeso, Baudax Bio) for the treatment of moderate to severe pain, either by itself or with other NSAID analgesics. FDA Approvals …read more
The FDA approved meloxicam injection (Anjeso, Baudax Bio) for the treatment of moderate to severe pain, either by itself or with other NSAID analgesics. FDA Approvals …read more
Updated guidance for osteoporosis now includes a recommendation for the use of romosozumab, but only in severe osteoporosis and not in women with a history of myocardial infarction or stroke. Medscape Medical News …read more